Alerts will be sent to your verified email
Verify Email
MANGALAM
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Mangalam Drugs and Organics Limited, an India-based company, specializes in manufacturing various chemicals including active pharma ingredients, perfumery, disperse dye intermediates, bulk drugs, and bulk drugs intermediates.
Mangalam Drugs&Org. major competitors are Lasa Supergenerics, Bal Pharma, Tyche Inds, Smruthi Organics, Nectar Lifesciences, Haleos Labs, Everest Organics.
Market Cap of Mangalam Drugs&Org. is ₹57 Crs.
While the median market cap of its peers are ₹134 Crs.
Mangalam Drugs&Org. seems to be less financially stable compared to its competitors.
Altman Z score of Mangalam Drugs&Org. is 1.73 and is ranked 5 out of its 8 competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | |||||||||||||||||||
| Investor Presentation | Mar Jun | Dec | |||||||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
